The clinical progress of haemoperfusion in the treatment of paraquat poisoning
10.3969/J.ISSN.1672-8270.2014.07.025
- VernacularTitle:血液灌流治疗百草枯中毒的临床研究进展
- Author:
Guoqiang LI
;
Pengbo YAN
;
Yuming LI
- Publication Type:Journal Article
- Keywords:
Charcoal haemoperfusion;
Paraquat poisoning;
Plasma perfusion;
Blood purification
- From:
China Medical Equipment
2014;(7):68-71
- CountryChina
- Language:Chinese
-
Abstract:
The high mortality of paraquat (PQ) poisonings is mainly due to the lack of effective treatments. Most toxicologists recommend rapid initiation of charcoal haemoperfusion (CHP) to lower plasma PQ levels and to limit pulmonary and other organs uptake of PQ. Although there are considerable evidences of CHP efficacy in the reversion of the fatal outcome resulting from PQ poisonings, the usefulness of this therapy has been the subject of significant controversy with several evidences published in the literature showing a lack of clinical benefit in numerous cases. Considering that the blood concentration at a given time is directly related to clinical outcome, the rebound in plasma paraquat concentration after haemoperfusion may be partly relate to the poor clinical benefit, but may indicate the necessity for prolonged haemoperfusion. Continuous rather than intermittent haemoperfusion has been advocated for treatment of paraquat poisoning. However, 24h daily conventional pump driven haemoperfusion is usually impossible to carry out due to bleeding complications. Plasmapheresis is also a blood purification process. Unselective therapeutic plasma exchange is the first technology used for therapeutic apheresis (TA). However, limited efficacy by restricted plasma volume that can be exchanged in a single session is one of the severe limitations. To further increase the clearance of target molecules, plasma perfusion (PP) techniques was developed. modification of the conventional plasma perfusion in patients with paraquat poisoning has been reported and plasma levels of paraquat were reduced effectively.
